VICO Therapeutics B.V.

VICO Therapeutics is a Leiden, Netherlands-based biotechnology company that focuses on developing RNA-modulating therapies for rare neurological disorders. Their mission is to bring innovative treatments to patients with genetic neurological diseases, and they are currently focused on developing antisense oligonucleotide (AON) therapies for Spinocerebellar Ataxia (SCA) and Huntington's Disease (HD). VICO's platform technology is built on their expertise in designing, manufacturing, and developing AONs as RNA modulating therapeutics, with a particular focus on targeting the CAG repeat expansion that causes these diseases.

VICO is a clinical-stage company with their lead product candidate, VO659, currently in Phase 1/2a clinical development for the treatment of SCA1, SCA3 and Huntington's Disease. Their VICOMER™ platform, which is built on AON technology, is designed to modulate RNA through various mechanisms including inhibition of translation, modulation of splicing, editing, degradation, and activation. They are committed to advancing their therapies for patients with severe, genetic neurological disorders and believe their approach has the potential to transform the lives of patients suffering from these devastating diseases.

VICO Therapeutics is a leading genetic medicine company focused on developing innovative RNA modulating therapies to treat patients with genetic neurological disorders. Their mission is to bring these therapies to patients with debilitating diseases such as Spinocerebellar Ataxia and Huntington's disease, who currently have limited treatment options. They are committed to building a company that fosters positive relationships with patients, physicians, partners, community members and employees.

VICO Therapeutics promotes a culture rooted in teamwork, respect, accountability, integrity, transparency, and service to patients and communities. They value collaboration and believe that their success is driven by a strong team spirit. They emphasize respect for each other and hold themselves accountable for their individual and collective actions. Integrity is paramount, building trust both within the company and with external stakeholders. They are transparent in their operations and prioritize serving the needs of patients and their communities.

VICO Therapeutics emphasizes the importance of a diverse and inclusive work environment, reflecting their commitment to serving a diverse patient population. They promote a culture of teamwork, respect, accountability, integrity, transparency, and service to patients and communities. This approach aims to foster collaboration among employees from various backgrounds, ensuring inclusivity and a sense of belonging for all.